Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xilio Therapeutics (XLO) Cash from Investing Activities (2024 - 2025)

Historic Cash from Investing Activities for Xilio Therapeutics (XLO) over the last 2 years, with Q2 2025 value amounting to -$401000.0.

  • Xilio Therapeutics' Cash from Investing Activities changed N/A to -$401000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was -$429000.0, marking a year-over-year change of. This contributed to the annual value of -$36000.0 for FY2024, which is 9259.26% up from last year.
  • Xilio Therapeutics' Cash from Investing Activities amounted to -$401000.0 in Q2 2025.
  • Over the past 5 years, Xilio Therapeutics' Cash from Investing Activities peaked at -$6000.0 during Q4 2024, and registered a low of -$401000.0 during Q2 2025.